These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
☐
|
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
☒
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
☐
|
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
|
Ordinary Shares, NIS 3.00 Nominal Value
|
|
ELTK
|
|
NASDAQ Capital Market
|
|
Large accelerated filer ☐
|
Accelerated filer ☐
|
|
Emerging growth company ☐
|
Non-accelerated filer ☒
|
|
U.S. GAAP ☒
|
International Financial Reporting Standards as issued by the International Accounting Standards Board ☐
|
Other ☐
|
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐
|
Page No.
|
|||
|
1
|
|||
|
1
|
|||
|
1
|
|||
|
1
|
|||
|
A.
|
Selected Financial Data
|
1
|
|
|
B.
|
Capitalization and Indebtedness
|
3
|
|
|
C.
|
Reasons for the Offer and Use of Proceeds
|
3
|
|
|
D.
|
Risk Factors
|
3
|
|
| 25 | |||
|
A.
|
History and Development of the Company
|
25
|
|
|
B.
|
Business Overview
|
26 | |
|
C.
|
Organizational Structure
|
32
|
|
|
D.
|
Property, Plants and Equipment
|
32 | |
| 33 | |||
|
33
|
|||
|
A.
|
Operating Results
|
33 | |
|
B.
|
Liquidity and Capital Resources
|
38 | |
|
C.
|
Research and Development, Patents and Licenses
|
41
|
|
|
D.
|
Trend Information
|
42 | |
|
E.
|
Off-Balance Sheet Arrangements
|
42 | |
|
F.
|
Tabular Disclosure of Contractual Obligations
|
42 | |
| 43 | |||
|
A.
|
Directors and Senior Management
|
43
|
|
|
B.
|
Compensation
|
45 | |
|
C.
|
Board Practices
|
47 | |
|
D.
|
Employees
|
54 | |
|
E.
|
Share Ownership
|
55 | |
| 56 | |||
|
A.
|
Major Shareholders
|
56 | |
|
B.
|
Related Party Transactions
|
58 | |
|
C.
|
Interests of Experts and Counsel
|
60
|
|
|
60
|
|||
|
A.
|
Consolidated Statements and Other Financial Information
|
60
|
|
|
B.
|
Significant Changes
|
61 | |
| 61 | |||
|
A.
|
Offer and Listing Details
|
61 | |
|
Page No.
|
|||
|
B.
|
Plan of Distribution
|
61 | |
|
C.
|
Markets
|
62 | |
|
D.
|
Selling Shareholders
|
62 | |
|
E.
|
Dilution
|
62 | |
|
F.
|
Expense of the Issue
|
62 | |
| 62 | |||
|
A.
|
Share Capital
|
62 | |
|
B.
|
Memorandum and Articles of Association
|
62 | |
|
C.
|
Material Contracts
|
63 | |
|
D.
|
Exchange Controls
|
63 | |
|
E.
|
Taxation
|
63
|
|
|
F.
|
Dividends and Paying Agents
|
73 | |
|
G.
|
Statement by Experts
|
73
|
|
|
H.
|
Documents on Display
|
73 | |
|
I.
|
Subsidiary Information
|
73 | |
| 73 | |||
| 74 | |||
| 74 | |||
|
74
|
|||
| 74 | |||
| 75 | |||
| 76 | |||
|
76
|
|||
|
76
|
|||
|
76
|
|||
|
77
|
|||
| 77 | |||
| 77 | |||
|
77
|
|||
| 78 | |||
| 78 | |||
| 78 | |||
| 79 | |||
| ITEM 1. |
IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS
|
| ITEM 2. |
OFFER STATISTICS AND EXPECTED TIMETABLE
|
| ITEM 3. |
KEY INFORMATION
|
|
Year ended December 31,
|
2020
|
2019
|
2018
|
2017
|
2016
|
|||||||||||||||
|
($ and share data in thousands, except per share data)
|
||||||||||||||||||||
|
Revenues
|
36,707
|
34,794
|
33,939
|
32,754
|
37,065
|
|||||||||||||||
|
Cost of revenues
|
(28,969
|
)
|
(28,787
|
)
|
(31,342
|
)
|
(31,427
|
)
|
(34,248
|
)
|
||||||||||
|
Gross profit
|
7,738
|
6,007
|
2,597
|
1,327
|
2,817
|
|||||||||||||||
|
R&D expenses
|
(2
|
)
|
(16
|
)
|
-
|
(41
|
)
|
(117
|
)
|
|||||||||||
|
Selling, general and administrative expenses
|
(4,704
|
)
|
(4,604
|
)
|
(4,669
|
)
|
(4,704
|
)
|
(4,699
|
)
|
||||||||||
|
Total operating expenses
|
(4,706
|
)
|
(4,620
|
)
|
(4,669
|
)
|
(4,744
|
)
|
(4,816
|
)
|
||||||||||
|
Operating profit (loss)
|
3,032
|
1,387
|
(2,072
|
)
|
(3,418
|
)
|
(1,999
|
)
|
||||||||||||
|
Financial expenses, net
|
(337
|
)
|
(440
|
)
|
(475
|
)
|
(298
|
)
|
(309
|
)
|
||||||||||
|
Other income (loss), net
|
(16
|
)
|
923
|
3
|
15
|
(259
|
)
|
|||||||||||||
|
Profit (loss) before income tax expense
|
2,679
|
1,870
|
(2,544
|
)
|
(3,701
|
)
|
(2,567
|
)
|
||||||||||||
|
Income tax (expense) benefit
|
(71
|
)
|
(77
|
)
|
(63
|
)
|
(74
|
)
|
(1,158
|
)
|
||||||||||
|
Net profit (loss)
|
2,608
|
1,793
|
(2,607
|
)
|
(3,775
|
)
|
(3,725
|
)
|
||||||||||||
|
Net profit (loss) attributable to non-controlling interest
|
-
|
-
|
-
|
-
|
101
|
|||||||||||||||
|
Net profit (loss) attributable to Eltek Ltd. shareholders
|
2,608
|
1,793
|
(2,607
|
)
|
(3,775
|
)
|
(3,624
|
)
|
||||||||||||
|
Basic and diluted net profit (loss) per ordinary share attributable to Eltek Ltd.
|
0.58
|
0.48
|
(1.28
|
)
|
(1.58
|
)
|
(1.82
|
)
|
||||||||||||
|
Weighted average number of ordinary shares used to compute basic net profit (loss) per ordinary share
|
4,495
|
3,734
|
2,029
|
2,029
|
2,029
|
|||||||||||||||
|
Weighted average number of ordinary shares used to compute diluted net profit (loss) per ordinary share
|
4,501
|
3,734
|
2,029
|
2,029
|
2,029
|
|||||||||||||||
|
|
As at December 31,
|
|||||||||||||||||||
|
|
2020
|
2019
|
2018
|
2017
|
2016
|
|||||||||||||||
|
($ and share data in thousands)
|
||||||||||||||||||||
|
Working capital (deficit)
|
9,119
|
(1,248
|
)
|
(5,314
|
)
|
(4,565
|
)
|
(93
|
)
|
|||||||||||
|
Total assets
|
35,157
|
22,829
|
18,160
|
22,145
|
20,145
|
|||||||||||||||
|
Long-term liabilities
|
10,189
|
1,794
|
519
|
911
|
2,098
|
|||||||||||||||
|
Total shareholders’ equity
|
15,267
|
6,269
|
882
|
3,459
|
6,634
|
|||||||||||||||
|
Number of issued and outstanding shares
|
5,840
|
4,380
|
2,029
|
2,029
|
2,029
|
|||||||||||||||
| • |
We have a history of operating losses and may not be able to achieve and sustain long term profitable operations. We may not have sufficient resources to fund our operations in the future.
|
| • |
We will require additional capital in the future, which may not be available to us.
|
| • |
The spread of novel strain of coronavirus, COVID-19, may adversely affect our business operations and financial condition.
|
| • |
We are dependent on one-of-a-kind machinery that may malfunction and may not be easily replaced.
|
| • |
Because competition in the PCB market is intense, our business, operating results and financial condition may be adversely affected
.
|
| • |
Rapid changes in the Israeli and international electronics industries and recessionary pressures may adversely affect our business.
|
| • |
Our products and product components need to meet certain industry standards.
|
| • |
Key customers account for a significant portion of our revenues. The loss of a key customer would have an adverse impact on our business results.
|
| • |
We are dependent upon a select number of suppliers for timely delivery of key raw materials and the loss of one or more of these suppliers or delays in supply of these raw materials would adversely affect our manufacturing ability. If
these suppliers delay or discontinue the manufacture or supply of these raw materials, we may experience delays in production and shipments, increased costs and cancellation of orders for our products.
|
| • |
Our results of operations may be adversely affected by currency fluctuations.
|
| • |
Unfavorable national and global economic conditions could adversely affect our business, operating results and financial condition.
|
| • |
We are subject to environmental laws and regulations. Compliance with those laws and regulations requires us to incur costs and we are subject to fines or other sanctions for non-compliance.
|
| • |
We have in the past been, and currently are, subject to claims and litigation relating to environmental matters. If we are found to be in violation of environmental laws, we could be liable for damages and costs of remediation and may
be subject to a halt in production, which may adversely affect our business, operating results and financial condition.
|
| • |
We may fail to be in compliance with financial covenants in our loan agreements.
|
| • |
We may not succeed in our efforts to expand our activity in the U.S. market. If we are unsuccessful, our future revenues and profitability would be adversely affected.
|
| • |
We may be subject to the requirements of the National Industrial Security Program Operating Manual for our facility security clearance, which is a prerequisite to our ability to work on classified contracts for the U.S. government.
|
| • |
We may encounter difficulties with our international operations and sales that may have a material adverse effect on our sales and profitability.
|
| • |
Compliance with the conditions of a new business permit issued to us in 2018, if required, may be costly. We may become subject to certain sanctions, including significant fines, criminal proceedings and in an unlikely event an
order shutting down our factory.
|
| • |
Damage to our manufacturing facilities due to fire, natural disaster, or other events could materially adversely affect our business, financial condition, and results of operations.
|
| • |
Our quarterly operating results fluctuate significantly. Results of operations in any period should not be considered indicative of the results to be expected for any future period.
|
| • |
Our products and related manufacturing processes are often highly complex and therefore we may be delayed in product shipments. Our products may at times contain manufacturing defects, which may subject us to product liability and
warranty claims. Our operating margins may be affected as a result of price increases for our principal raw materials.
|
| • |
Increasing scrutiny and changing expectations from investors, lenders, customers and other market participants with respect to our Environmental, Social and Governance policies may impose additional costs on us or expose us to
additional risks.
|
| • |
We compete with PCB manufacturers in Asia whose manufacturing costs are lower than ours.
|
| • |
We may fail to maintain effective internal control over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act of 2002, which could have a material adverse effect on our operating results, investor confidence in
our reported financial information, and the market price of our ordinary shares.
|
| • |
We are required to comply with “conflict minerals” rules which impose costs on us, may make our supply chain more complex, and could adversely impact our business.
|
| • |
Increased regulation associated with climate change and greenhouse gas emissions could impose significant additional costs on operations.
|
| • |
Obstacles in our transition to a new enterprise resource planning system may adversely affect our business and results of operations and the effectiveness of our internal control over financial reporting.
|
| • |
Breaches of network or information technology security, natural disasters or terrorist attacks could have an adverse effect on our business.
|
| • |
Technological change may adversely affect the market acceptance of our products.
|
| • |
The measures we take in order to protect our intellectual property may not be effective or sufficient.
|
| • |
Claims that our products infringe upon the intellectual property of third parties may require us to incur significant costs.
|
| • |
If our workforce will be represented by a labor union we could incur additional costs or experience work stoppages as a result of the renegotiation of our labor contracts.
|
| • |
From time to time, we may be named as a defendant in actions involving the alleged violation of labor laws related to employment practices, wages and benefits.
|
| • |
Under current Israeli law, we may not be able to enforce covenants not to compete and therefore may be unable to prevent our competitors from benefiting from the expertise of some of our former employees.
|
| • |
We depend on key personnel for the success of our business.
|
| • |
Our ability to have access to insurance programs for
directors
and officers may be curtailed, which may adversely affect our ability to retain and attract directors and officers.
|
| • |
Our share price has been volatile in the past and may continue to be susceptible to significant market price and volume fluctuations in the future.
|
| • |
The voting interest of Mr. Nissan, individually and through Nistec Golan, our controlling shareholder, may conflict with the interests of other shareholders.
|
| • |
If we fail to maintain compliance with NASDAQ’s continued listing requirements our shares may be delisted from the NASDAQ Capital Market.
|
| • |
Penny stock rules may limit the ability of our stockholders to sell their stock.
|
| • |
We may in the future be classified as a passive foreign investment company, or PFIC, which would subject our U.S. investors to adverse tax rules.
|
| • |
We do not expect to distribute dividends in the foreseeable future.
|
| • |
Political, economic and military instability in Israel may disrupt our operations and negatively affect our business condition, harm our results of operations and adversely affect our share price.
|
| • |
Our results of operations may be negatively affected by the obligation of our personnel to perform military reserve service.
|
| • |
Service and enforcement of legal process on us and our directors and officers may be difficult to obtain.
|
| • |
Provisions of Israeli law may delay, prevent or make difficult an acquisition of us, which could prevent a change of control and therefore impact the price of our shares.
|
| • |
The rights and responsibilities of our shareholders are governed by Israeli law and differ in some respects from the rights and responsibilities of shareholders under U.S. law.
|
| • |
The termination or reduction of tax and other incentives that the Israeli government provides to domestic companies may increase the costs involved in operating a company in Israel.
|
|
|
• |
the impact of possible recessionary environments or economic instability in multiple foreign markets;
|
|
|
• |
changes in regulatory requirements and complying with a wide variety of foreign laws;
|
|
|
• |
tariffs and other trade barriers;
|
|
|
• |
the imposition of exchange or price controls or other restrictions on the conversion of foreign currencies; and
|
|
|
• |
difficulties and costs of staffing and managing foreign operations.
|
|
|
• |
the size and timing of significant orders and their fulfillment;
|
|
|
• |
demand for our products and the mix of products purchased by our customers;
|
|
|
• |
competition from lower priced manufacturers;
|
|
|
• |
fluctuations in foreign currency exchange rates, primarily the NIS against the Dollar and the Euro;
|
|
|
• |
manufacturing yield;
|
|
|
• |
plant utilization;
|
|
|
• |
availability of raw materials;
|
|
|
• |
plant or line shutdowns to repair or replace malfunctioning manufacturing equipment;
|
|
|
• |
the length of our sales cycles;
|
|
|
• |
changes in our strategy;
|
|
|
• |
the number of working days in the quarter;
|
|
|
• |
changes in seasonal trends; and
|
|
|
• |
general domestic and international economic and political conditions.
|
|
|
• |
retain our executive officers and key technical personnel;
|
|
|
• |
attract and retain additional qualified personnel to provide technological depth and support to enhance existing products and develop new products; and
|
|
|
• |
attract and retain highly skilled operations, marketing and financial personnel.
|
|
|
• |
quarterly variations in our operating results;
|
|
|
• |
operating results that vary from the expectations of securities analysts and investors;
|
|
|
• |
changes in expectations as to our future financial performance, including financial estimates by securities analysts and investors;
|
|
|
• |
announcements of technological innovations or new products by us or our competitors;
|
|
|
• |
announcements by us or our competitors of significant contracts, acquisitions, strategic partnerships, joint ventures or capital commitments;
|
|
|
• |
changes in the status of our intellectual property rights;
|
|
|
• |
announcements by third parties of significant claims or proceedings against us;
|
|
|
• |
announcements by governmental or regulatory authorities of significant investigations or proceedings against us;
|
|
|
• |
additions or departures of key personnel;
|
|
|
• |
changes in our cost structure due to factors beyond our control, such as new laws or regulations relating to environmental matters and employment;
|
|
|
• |
future sales of our ordinary shares;
|
|
|
• |
our involvement in litigation;
|
|
|
• |
general stock market price and volume fluctuations;
|
|
|
• |
changes in the prices of our products and services; and
|
|
|
• |
devaluation of the dollar against the NIS.
|
| ITEM 4A. | UNRESOLVED STAFF COMMENTS |
| ITEM 5. |
OPERATING AND FINANCIAL REVIEW AND PROSPECTS
|
|
Year Ended December 31,
|
||||||||||||
|
2020
|
2019
|
2018
|
||||||||||
|
Revenues
|
100
|
%
|
100
|
%
|
100
|
%
|
||||||
|
Cost of revenues
|
(78.9
|
)
|
(82.7
|
)
|
(92.3
|
)
|
||||||
|
Gross profit
|
21.1
|
17.3
|
7.7
|
|||||||||
|
Selling, general and administrative expenses
|
(12.8
|
)
|
(13.3
|
)
|
(13.8
|
)
|
||||||
|
Operating profit (loss)
|
8.3
|
4.0
|
(6.1
|
)
|
||||||||
|
Financial expenses, net
|
(0.9
|
)
|
(1.3
|
)
|
(1.4
|
)
|
||||||
|
Other income (loss), net
|
(0.1
|
)
|
2.7
|
*
|
||||||||
|
Profit (loss) before income tax expense
|
7.3
|
5.4
|
(7.5
|
)
|
||||||||
|
Income tax (expense)
|
(0.2
|
)
|
(0.2
|
)
|
(0.2
|
)
|
||||||
|
Net profit (loss)
|
7.1
|
5.2
|
(7.7
|
)
|
||||||||
|
Year Ended December 31,
|
||||||||||||||||||||
|
2020
|
2019
|
2018
|
2017
|
2016
|
||||||||||||||||
|
Dollar
|
(7.0
|
)%
|
(7.8
|
)%
|
8.1
|
%
|
(9.8
|
)%
|
(1.5
|
)%
|
||||||||||
|
Euro
|
1.7
|
%
|
(9.6
|
)%
|
3.3
|
%
|
2.7
|
%
|
(4.8
|
)%
|
||||||||||
|
Israeli CPI
|
(0.7
|
)%
|
0.6
|
%
|
0.8
|
%
|
0.4
|
%
|
(0.2
|
)%
|
||||||||||
|
|
• |
A loan amount of NIS 5 million carried interest of Prime + 1% from September 26, 2019 until January 7, 2020.
|
|
|
• |
A second loan amount of NIS 5 million carried interest of Prime + 1.75%, from January 1, 2019 until it was repaid in full in December 2020.
|
|
Year ended December 31,
|
2020
|
2019
|
2018
|
|||||||||
|
($ in thousands)
|
||||||||||||
|
Net cash provided by (used in) operating activities
|
3,252
|
2,578
|
(813
|
)
|
||||||||
|
Net cash used in investing activities
|
(1,140
|
)
|
(806
|
)
|
(619
|
)
|
||||||
|
Net cash provided by (used in) financing activities
|
814
|
(1,132
|
)
|
1,527
|
||||||||
|
Effect of translation adjustments
|
181
|
(4
|
)
|
10
|
||||||||
|
Net increase in cash and cash equivalents
|
3,107
|
636
|
105
|
|||||||||
|
Cash and cash equivalents at beginning of year
|
1,628
|
992
|
887
|
|||||||||
|
Cash and cash equivalents at end of year
|
4,735
|
1,628
|
992
|
|||||||||
|
Contractual Obligations
|
Payments due by period
($ in thousands) |
|||||||||||||||||||
|
Total
|
less than 1 year
|
2-3 years
|
4-5 years
|
more than 5 years
|
||||||||||||||||
|
Short-term bank credit
(1)
|
676
|
676
|
-
|
-
|
-
|
|||||||||||||||
|
Long-term debt obligations
(1)
|
1,562
|
66
|
1,011
|
485
|
-
|
|||||||||||||||
|
Operating lease
|
6,419
|
1,021
|
2,059
|
2,119
|
1,220
|
|||||||||||||||
|
Other contractual obligations
|
2,761
|
612
|
882
|
737
|
530
|
|||||||||||||||
|
Purchase obligations
|
1,358
|
1,358
|
-
|
-
|
-
|
|||||||||||||||
|
Other short-term liabilities reflected on the company’s balance sheet
)
|
3,703
|
3,703
|
-
|
-
|
-
|
|||||||||||||||
|
Other long-term liabilities reflected on the company’s balance sheet
|
410
|
-
|
-
|
-
|
410
|
|||||||||||||||
|
Estimate of interest payments on long-term debt obligations
(2)
|
113
|
49
|
54
|
10
|
-
|
|||||||||||||||
|
Total
|
17,002
|
7,485
|
4,006
|
3,351
|
2,160
|
|||||||||||||||
| (1) |
Long-term debt obligations include current maturities to be paid in the next 12 months. For information on the interest rates of our short-term bank credit and long-term debt obligations, see Item 5B. “Operating and Financial Review
and Prospects - Liquidity and Capital Resources.”
|
| (2) |
The estimate of interest payments on long-term debt obligations is based on current interest rates as of December 31, 2020 (including current variable rates on the existing long-term debt obligations) and on the current volume of debt
obligations, assuming loan repayment in future years as disclosed in Note 8 to the consolidated financial statements.
|
| ITEM 6. |
DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES
|
|
Name
|
Age
|
Position
|
|
Yitzhak Nissan
(3)
|
71
|
Chairman of the Board of Directors
|
|
Mordechai Marmorstein
(1)(2)
|
74
|
Director
|
|
David Rubner
(4)
|
81
|
Director
|
|
Erez Meltzer
(4)
|
63
|
Director
|
|
Gad Dovev
(1)(2)(3)(4)
|
74
|
External Director
|
|
Ilana Lurie
(1)(2)(3)(4)
|
48
|
External Director
|
|
Name
|
Age
|
Position
|
|
Eli Yaffe
|
66
|
Chief Executive Officer
|
|
Alon Mualem
|
53
|
Chief Financial Officer
|
|
Yitzhak Zemach
Oriel Sallary
|
45
58
|
Director of Operations
VP Sales and Marketing
|
|
Sagi Balter
|
40
|
VP Process Engineering
|
|
Shmuel Meidan
|
60
|
VP Quality Assurance
|
|
Salaries, fees,
commissions and bonuses
|
Pension, retirement
and similar benefits
|
||
|
All directors and executive officers as a group (consisting of 12
persons)
|
$1.6 million
(1)
|
$365,000
(2)
|
|
|
(1) |
During the year ended December 31, 2020, we paid each of our directors an annual fee of approximately $8,400 and an attendance fee of $270 per meeting. These fees are included in the above amount.
|
|
|
(2) |
The benefits amount includes expenses for automobiles and other benefits that we provide to certain of our executive officers.
|
|
Name of Officer
|
Position of Officer
|
Compensation for services (USD)
(1)
|
||||||||||||||
|
|
|
Base salary
|
|
Benefits and
Perquisites (2) |
|
Equity-
Based
(3)
|
|
Total
compensation
|
||||||||
|
Yitzhak Nissan
(4)
|
Chairman of the Board
|
314,255
|
-
|
-
|
314,255
|
|||||||||||
|
Eli Yaffe
|
Chief Executive Officer
|
272,723
|
330,708
|
40,346
|
643,777
|
|||||||||||
|
Alon Mualem
|
Chief Financial Officer
|
156,273
|
148,087
|
5,722
|
310,082
|
|||||||||||
|
Yitzhak Zemach
|
VP Operations
|
119,937
|
100,717
|
11,758
|
232,412
|
|||||||||||
|
Richard Smith
|
Vice President of Sales, US Western Region
|
164,051
|
27,392
|
-
|
191,443
|
|||||||||||
|
|
(1)
|
Cash compensation amounts denominated in NIS were converted into U.S. dollars at the rate of NIS 3.437 per $1.00 (the average exchange rate in 2020).
|
|
|
(2)
|
Amounts reported in this column include benefits and perquisites, including those mandated by applicable law. Such benefits and perquisites may include, to the extent applicable, bonuses, car related
expenses, managers’ insurance and pension funds, payments to the National Insurance Institute, advanced education funds, medical insurance, vacation allowance and other customary benefits. Bonuses represent accrued but not yet paid bonus
payments for 2020, based on several criteria, including revenues, profit, employees’ safety, yield and on time deliveries.
|
|
(3)
|
Represents the equity-based compensation expenses recorded in the company’s consolidated financial statements for the year ended December 31, 2020 based on the options’ grant date fair value in accordance with accounting guidance for
equity-based compensation.
|
|
|
(4)
|
Paid to Nistec as management fees.
|
|
|
(i) |
the board of directors proposed the nominee and his appointment was approved by the shareholders in the manner required to appoint external directors for their initial term;
|
|
|
(ii) |
a shareholder holding 1% or more of the voting rights proposed the nominee, and the nominee is approved by a majority of the votes cast by the shareholders of the company on the matter, excluding the votes of controlling shareholders
and those who have a personal interest in the matter as a result of their relationship with any controlling shareholder and excluding abstentions, provided that the aggregate votes cast by shareholders who are not controlling shareholders
and do not have a personal interest in the matter as a result of their relationship with the controlling shareholders voted in favor of the reelection of the nominee constitute more than 2% of the voting rights in the company, and
provided further that at the time of such nomination or in the two years preceding such nomination, such external director or his relative are neither the shareholder who proposed such nomination, or a shareholder holding 5% or more of
the company's issued share capital or voting power, in each case who, or whose controlling shareholder or any entity controlled by them (i) has business relations with the company, or (ii) is a competitor of the company; or
|
|
|
(iii) |
such external director nominates himself or herself for each such additional term and his or her election is approved at a shareholders meeting by the same disinterested majority as required for the election of an external director
nominated by a 1% or more shareholder (as described above).
|
|
|
i. |
a monetary obligation imposed on the office holder in favor of another person pursuant to a judgment, including a judgment given in settlement or an arbitrator's award that has been approved by a court;
|
|
|
ii. |
reasonable litigation expenses, including advocates’ professional fees, incurred by the office holder pursuant to an investigation or a proceeding commenced against the office holder by a competent authority and that was terminated
without an indictment and without having a monetary charge imposed on the office holder in exchange for a criminal procedure (as such terms are defined in the Israeli Companies Law), or that was terminated without an indictment but with a
monetary charge imposed on the office holder in exchange for a criminal procedure in a crime that does not require proof of criminal intent or in connection with a financial sanction;
|
|
|
iii. |
reasonable litigation expenses, including advocates’ professional fees, incurred by the office holder or which the office holder is ordered to pay by a court, in proceedings filed against the office holder by the company or on its
behalf or by another person, or in a criminal indictment in which the office holder is acquitted, or in a criminal indictment in which the office holder is convicted of an offence that does not require proof of criminal intent;
|
|
|
iv. |
expenses, including reasonable litigation expenses and legal fees, incurred by an office holder as a result of a proceeding instituted against such office holder in relation to (A) infringements that may result in imposition of
financial sanction pursuant to the provisions of Chapter H'3 under the Israeli Securities Law or (B) administrative infringements pursuant to the provisions of Chapter H'4 under the Israeli Securities Law or (C) infringements pursuant to
the provisions of Chapter I'1 under the Israeli Securities Law; and
|
|
|
v. |
payments to an injured party of infringement under Section 52ND(a)(1)(a) of the Israeli Securities Law.
|
|
Name
|
Number of Ordinary Shares Beneficially Owned
|
Percentage of Outstanding Ordinary Shares
(2)
|
||||||
|
Yitzhak Nissan
(1)
|
4,065,912
|
69.6
|
%
|
|||||
|
All executive officers and directors as a group (12 persons)
(3)
|
4,134,105
|
70.0
|
%
|
|||||
| ITEM 7. |
MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS
|
|
Name
|
Number of Ordinary Shares
Beneficially Owned
(1)
|
Percentage
of Ownership
(2)
|
||||||
|
Nistec Golan Ltd.
(3)
|
3,891,596
|
66.63
|
%
|
|||||
|
Yitzhak Nissan
(3)
|
174,316
|
2.98
|
%
|
|||||
|
|
(1) |
Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Ordinary shares relating to options or convertible notes currently exercisable or
exercisable within 60 days of the date of this table are deemed outstanding for computing the percentage of the person holding such securities but are not deemed outstanding for computing the percentage of any other person. Except as
indicated by footnote, and subject to community property laws where applicable, the persons named in the table above have sole voting and investment power with respect to all shares shown as beneficially owned by them.
|
|
|
(2) |
The percentages shown are based on 5,840,357 ordinary shares issued and outstanding as of March 22, 2021.
|
|
|
(3) |
Based on a Schedule 13D/A filed on February 16, 2021. In addition, Nistec Ltd. transferred its shares to Nistec Golan in December 2018. Nistec Golan is an Israeli private company controlled by Yitzhak Nissan. Accordingly, Mr. Nissan
may be deemed to be the beneficial owner of the ordinary shares held directly by Nistec.
|
|
|
• |
Mr. Nissan will receive reimbursement of travel expenses (other than food and beverage expenses) while traveling internationally on behalf of our company, provided that such reimbursement shall not exceed an aggregate amount of NIS
10,000 per calendar quarter.
|
|
|
• |
Mr. Nissan will receive reimbursement of food and beverage expenses while traveling internationally on behalf of our company, against receipts, in accordance with the Israeli Income Tax Regulations (Deduction of Certain Expenses)
5732-1972.
|
|
|
i. |
The extension of the Amended PCB Purchase Procedure with Nistec Ltd.;
|
|
|
ii. |
The extension of the amended general engagement terms, processes and restrictions of the Soldering and Assembly Services Procedure with Nistec Ltd.;
|
|
|
iii. |
The extension of the procedure under which we and Nistec Ltd. may jointly acquire certain services related to employees social activities, marketing services and insurance.
|
|
|
• |
In June 2017, we received a loan of NIS 5.0 million (approximately $1.4 million) from Nistec. In March 2018, we received additional loans from Nistec, of NIS 4.0 million (approximately $1.2 million), and in July 2018, we received a
third loan from Nistec, of NIS 1.0 million (approximately $290,000) (together, the “Loans”). In December 2018, the Loans and Nistec’s shares were transferred internally within the Nistec group to an affiliated company, Nistec Golan Ltd.
On December 5, 2019, our shareholders approved the execution of an amended interest agreement with Nistec Golan (the “Interest Agreement”). Under the terms of the Interest Agreement (any accrued interest prior to the date of the
Interest Agreement was waived by Nistec Golan), the Loans, which were repaid from the proceeds of our December 2020 rights offering, carried interest, as follows: A loan in the amount of NIS 5 million carried interest of Prime + 1%, from
September 26, 2019 until January 7, 2020.
|
|
|
• |
A second loan amount of NIS 5 million carried interest of Prime + 1.75%, from January 1, 2019 until December 2020.
|
| ITEM 8. |
FINANCIAL INFORMATION
|
| ITEM 9. |
THE OFFER AND LISTING
|
| ITEM 10. |
ADDITIONAL INFORMATION
|
|
|
• |
broker-dealers;
|
|
|
• |
financial institutions or financial services entities;
|
|
|
• |
investors liable for alternative minimum tax;
|
|
|
• |
regulated investment companies, real estate investment trusts, or grantor trusts;
|
|
|
• |
tax-exempt organizations;
|
|
|
• |
retirement plans;
|
|
|
• |
S corporations:
|
|
|
• |
pension funds;
|
|
|
• |
certain former citizens or long-term residents of the United States;
|
|
|
• |
non-resident aliens of the United States or taxpayers whose functional currency is not the U.S. dollar;
|
|
|
• |
persons who hold ordinary shares through partnerships or other pass-through entities;
|
|
|
• |
persons who acquire their ordinary shares through the exercise or cancellation of employee stock options or otherwise as compensation for services;
|
|
|
• |
direct, indirect or constructive owners of investors that actually or constructively own at least 10% of the total combined voting power of our shares or at least 10% of our shares by value; or
|
|
|
• |
investors holding ordinary shares as part of a straddle, appreciated financial position, a hedging transaction or conversion transaction.
|
|
|
• |
an individual who is a citizen or a resident of the United States;
|
|
|
• |
a corporation or other entity taxable as a corporation for United States federal income tax purposes, created or organized in or under the laws of the United States or any political subdivision thereof;
|
|
|
• |
an estate the income of which is subject to U.S. federal income taxation regardless of its source; or
|
|
|
• |
a trust if the trust has validly elected to be treated as a U.S. person for U.S. federal income tax purposes or if (1) a court within the United States is able to exercise primary supervision over the trust’s administration and (2) one
or more U.S. persons have the authority to control all of the substantial decisions of the trust.
|
| ITEM 11. |
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKS
|
| ITEM 12. |
DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES
|
| ITEM 13. |
DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES
|
| ITEM 14. |
MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS
|
| ITEM 15. |
CONTROLS AND PROCEDURES
|
|
|
• |
pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of our company;
|
|
|
• |
provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of our company are
being made only in accordance with authorizations of management and directors of our company; and
|
|
|
• |
provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our company’s assets that could have a material effect on our financial statements.
|
| ITEM 16. |
[RESERVED]
|
| ITEM 16B. |
CODE OF ETHICS
|
| ITEM 16C. |
PRINCIPAL ACCOUNTANT FEES AND SERVICES
|
|
Services Rendered.
|
2020
|
2019
|
2018
|
|||||||||
|
Audit
(1)
|
$
|
75,000
|
$
|
85,000
|
$
|
85,000
|
||||||
|
Audit Related Fees
|
27,500
|
33,700
|
55,000
|
|||||||||
|
Tax
(2)
|
-
|
-
|
-
|
|||||||||
|
All other Fees
(3)
|
5,600
|
7,620
|
6,700
|
|||||||||
|
Total
|
$
|
108,100
|
$
|
126,320
|
$
|
146,700
|
||||||
|
|
(1) |
Audit fees relate to audit services provided for each of the years shown in the table, including fees associated with the annual audit, consultations on various accounting issues and audit services provided in connection with statutory
or regulatory filings.
|
|
|
(2) |
Tax fees relate to services performed regarding tax compliance.
|
|
|
(3) |
Other fees are fees for professional services other than audit or tax related fees.
|
| ITEM 16D. |
EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES
|
| ITEM 16E. |
PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS
|
| ITEM 16F. |
CHANGES IN REGISTRANT’S CERTIFYING ACCOUNTANT
|
| ITEM 16G. |
CORPORATE GOVERNANCE
|
|
|
• |
The requirement to maintain a majority of independent directors, as defined under the NASDAQ Stock Market Rules. Instead, we follow Israeli law and practice which requires that we appoint at least two external directors, within the
meaning of the Israeli Companies Law, to our board of directors. We have the mandated three independent directors, within the meaning of the rules of the SEC and NASDAQ, on our audit committee. See Item 6C. “Directors, Senior Management
and Employees - Board Practices - External and Independent Directors.”
|
|
|
• |
The requirements regarding the directors’ nominations process. Under Israeli law and practice, our board of directors is authorized to recommend to our shareholders director nominees for election. See Item 6C.
–
“Directors, Senior Management and Employees - Board Practices - Election of Directors.”
|
|
|
• |
The requirement regarding the quorum for any meeting of shareholders. Instead, we follow Israeli law and practice which provides that, unless otherwise provided by a company’s articles of association, the quorum required for a general
meeting of shareholders is at least two shareholders present who hold, in the aggregate, 25% of the company’s voting rights. Our articles of association provide that the quorum required for a shareholder meeting consists of at least two
shareholders present in person or represented by proxy who hold or represent, in the aggregate, at least 33% of the voting rights of the issued share capital. See Item 10A. “Additional Information - Share Capital - Annual and
Extraordinary Meetings of Shareholders.”
|
| ITEM 16H. |
MINE SAFETY DISCLOSURE
|
| ITEM 17. |
FINANCIAL STATEMENTS
|
| ITEM 18. |
FINANCIAL STATEMENTS
|
|
|
Page
|
|
|
Reports of Independent Registered Public Accounting Firms
|
F - 1
|
|
|
Consolidated Balance Sheets
|
F - 4
|
|
|
Consolidated Statements of Comprehensive Income (loss)
|
F - 6
|
|
|
Consolidated Statements of Changes in Shareholders’ Equity
|
F - 7
|
|
|
Consolidated Statements of Cash Flows
|
F - 8 - F - 9
|
|
|
Notes to the Consolidated Financial Statements
|
F - 10 - F - 43
|
| ITEM 19. |
EXHIBITS
|
|
Exhibit
|
|
Description
|
|
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
Consent of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global (9) | |
| 16 |
|
Letter from Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global (9) |
|
101.INS
|
|
XBRL Instance Document.
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document.
|
|
101.PRE
|
|
XBRL Taxonomy Presentation Linkbase Document.
|
|
101.CAL
|
|
XBRL Taxonomy Calculation Linkbase Document.
|
|
101.LAB
|
|
XBRL Taxonomy Label Linkbase Document.
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
|
|
(1)
|
Filed as Exhibit 1.1 to our registration statement on Form F-1, registration number 333-229740, as amended, and incorporated herein by reference.
|
|
|
|
(2)
|
Included in Exhibit 99.1 to our Report of Foreign Issuer on Form 6-K filed on September 12, 2013 and incorporated herein by reference.
|
|
|
|
(3)
|
Filed as Exhibit 2.1 to our registration statement on Form F-1, registration number 333-229740, as amended, and incorporated herein by reference.
|
|
|
(4)
|
Included as Exhibit B to Exhibit 99.1 to our Report of Foreign Issuer on Form 6-K filed on October 31, 2019 and incorporated herein by reference.
|
||
|
|
(5)
|
Included as Exhibit A to Exhibit 99.1 to our Report of Foreign Issuer on Form 6-K filed on October 31, 2019 and incorporated herein by reference.
|
|
| (6) |
Filed as Exhibit 4.11 to our Annual Report on Form 20-F for the year ended December 31, 2014, and incorporated herein by reference.
|
||
| (7) |
Filed as Exhibit 4.12 to our Annual Report on Form 20-F for the year ended December 31, 2014, and incorporated herein by reference.
|
||
| (8) |
Filed as Exhibit 4.13 to our Annual Report on Form 20-F for the year ended December 31, 2014, and incorporated herein by reference.
|
||
| (9) |
Filed herewith.
|
||
|
Page
|
||
|
F - 1
|
||
|
F - 4
|
||
|
F - 6
|
||
|
F - 7
|
||
|
F - 8 - F - 9
|
||
|
F - 10 - F - 43
|
|
|
• |
We obtained an understanding of the process and assumptions used by management to develop the inventory excess and obsolete write offs, through inquiries of the Company's personnel and evaluation of the Company's methodology for
determining inventory that is excess or obsolete.
|
|
|
• |
We evaluated the assumptions used by the Company to define what is considered aged inventory by assessing historical trends in the Company’s product life cycle as well as evaluating the underlying calculations applied to the aged
inventory.
|
|
|
• |
For a sample of inventory items with an associated write off for excess and obsolescence, we evaluated whether the write-off for each selection was reasonable by obtaining and evaluating evidence of past usage and aging of the
inventory item.
|
|
|
• |
We tested the accuracy of the Company’s inventory valuation calculations utilizing its defined methodology and evaluated the completeness, accuracy, and relevance of the underlying data used in management's estimate.
|
|
|
• |
We compared management’s prior-year inventory reserve estimate to the amount of inventory written off or otherwise disposed of during the current year to consider potential bias in the determination of the inventory reserves.
|
|
Kost Forer Gabbay & Kasierer
144 Menachem Begin Road, Building A,
Tel-Aviv 6492102, Israel
|
Tel: +972-3-6232525
Fax: +972-3-5622555
ey.com
|
|
KOST FORER GABBAY & KASIERER
|
|
A Member of Ernst & Young Global
|
|
Tel-Aviv, Israel
|
|
April 27, 2020
|
|
December 31,
|
||||||||||||
|
Note
|
2020
|
2019
|
||||||||||
|
ASSETS
|
||||||||||||
|
CURRENT ASSETS:
|
||||||||||||
|
Cash and cash equivalents
|
3
|
4,735
|
1,628
|
|||||||||
|
Trade receivables (net of allowance for doubtful accounts of $214 and $227 at December 31, 2020 and December 31, 2019, respectively)
|
1f
|
|
9,062
|
7,480
|
||||||||
|
Inventories
|
4
|
3,704
|
3,735
|
|||||||||
|
Other accounts receivable and prepaid expenses
|
5
|
1,319
|
675
|
|||||||||
|
Total
current assets
|
18,820
|
13,518
|
||||||||||
|
LONG-TERM ASSETS:
|
||||||||||||
|
Severance pay fund
|
10
|
64
|
60
|
|||||||||
|
Restricted deposit
|
62
|
-
|
||||||||||
|
Operating lease right-of-use assets
|
11
|
8,948
|
2,490
|
|||||||||
|
Property and equipment, net
|
6
|
7,263
|
6,761
|
|||||||||
|
Total
long-term assets
|
16,337
|
9,311
|
||||||||||
|
Total
assets
|
35,157
|
22,829
|
||||||||||
|
December 31,
|
||||||||||||
|
Note
|
2020
|
2019
|
||||||||||
|
LIABILITIES AND SHAREHOLDERS' EQUITY
|
||||||||||||
|
CURRENT LIABILITIES:
|
||||||||||||
|
Short-term credit and current maturities of long-term debt
|
7
|
676
|
2,120
|
|||||||||
|
Short-term loan from related party
|
20a
|
|
-
|
3,472
|
||||||||
|
Trade payables
|
4,452
|
4,673
|
||||||||||
|
Other accounts payable and accrued expenses
|
8
|
3,831
|
3,118
|
|||||||||
|
Short-term operating lease liabilities
|
11
|
742
|
1,383
|
|||||||||
|
Total
current liabilities
|
9,701
|
14,766
|
||||||||||
|
LONG-TERM LIABILITIES:
|
||||||||||||
|
Long-term debt, excluding current maturities
|
9
|
1,495
|
387
|
|||||||||
|
Accrued severance pay
|
10
|
338
|
268
|
|||||||||
|
Deferred tax liabilities
|
18
|
84
|
45
|
|||||||||
|
Long-term operating lease liabilities
|
11
|
8,272
|
1,094
|
|||||||||
|
Total
long-term liabilities
|
10,189
|
1,794
|
||||||||||
|
COMMITMENTS AND CONTINGENT LIABILITIES
|
12
|
-
|
-
|
|||||||||
|
SHAREHOLDERS' EQUITY:
|
||||||||||||
|
Share capital -
|
||||||||||||
|
Ordinary shares of NIS 3.0 par value –
Authorized: 10,000,000 shares at December 31, 2020 and December 31, 2019; Issued and outstanding: 5,840,357 and 4,380,268 shares at December 31, 2020 and
December 31, 2019, respectively
|
5,296
|
3,964
|
||||||||||
|
Additional paid-in capital
|
22,846
|
18,583
|
||||||||||
|
Foreign currency translation adjustments
|
3,153
|
2,479
|
||||||||||
|
Capital reserves
|
1,084
|
963
|
||||||||||
|
Accumulated deficit
|
(17,112
|
)
|
(19,720
|
)
|
||||||||
|
Total
shareholders' equity
|
13
|
15,267
|
6,269
|
|||||||||
|
Total
liabilities and shareholders' equity
|
35,157
|
22,829
|
||||||||||
|
Year ended
December 31,
|
||||||||||||||||
|
Note
|
2020
|
2019
|
2018
|
|||||||||||||
|
Revenues
|
15b
|
|
36,707
|
34,794
|
33,939
|
|||||||||||
|
Cost of revenues
|
(28,969
|
)
|
(28,787
|
)
|
(31,342
|
)
|
||||||||||
|
Gross profit
|
7,738
|
6,007
|
2,597
|
|||||||||||||
|
Operating expenses:
|
||||||||||||||||
|
Research and development, net
|
(2
|
)
|
(16
|
)
|
-
|
|||||||||||
|
Selling, general and administrative
|
(4,704
|
)
|
(4,604
|
)
|
(4,669
|
)
|
||||||||||
|
Operating income (loss)
|
3,032
|
1,387
|
(2,072
|
)
|
||||||||||||
|
Financial expenses, net
|
16
|
(337
|
)
|
(440
|
)
|
(475
|
)
|
|||||||||
|
Other income (expenses), net
|
17
|
(16
|
)
|
923
|
3
|
|||||||||||
|
Income (loss) before income taxes
|
2,679
|
1,870
|
(2,544
|
)
|
||||||||||||
|
Taxes on income
|
18
|
(71
|
)
|
(77
|
)
|
(63
|
)
|
|||||||||
|
Net income (loss)
|
2,608
|
1,793
|
(2,607
|
)
|
||||||||||||
|
Other comprehensive income (loss):
|
||||||||||||||||
|
Foreign currency translation adjustments
|
674
|
139
|
(75
|
)
|
||||||||||||
|
Total comprehensive income (loss)
|
3,282
|
1,932
|
(2,682
|
)
|
||||||||||||
|
Basic and diluted income (loss) per ordinary share attributable to Eltek Ltd. shareholders
|
14
|
0.58
|
0.48
|
(1.28
|
)
|
|||||||||||
|
Company's shareholders
|
||||||||||||||||||||||||||||
|
Ordinary shares
|
Amount
|
Additional paid-in capital
|
Accumulated other comprehensive income (loss)
|
Capital
reserves
|
Accumulated deficit
|
Total
|
||||||||||||||||||||||
|
Balance as of January 1, 2018
|
2,028,552
|
1,985
|
17,270
|
2,415
|
695
|
(18,906
|
)
|
3,459
|
||||||||||||||||||||
|
Stock-based compensation
|
-
|
-
|
-
|
-
|
56
|
-
|
56
|
|||||||||||||||||||||
|
Transaction with controlling shareholder
|
-
|
-
|
-
|
-
|
49
|
-
|
49
|
|||||||||||||||||||||
|
Comprehensive income (loss):
|
||||||||||||||||||||||||||||
|
Foreign currency translation adjustments
|
-
|
-
|
-
|
(75
|
)
|
-
|
-
|
(75
|
)
|
|||||||||||||||||||
|
Net loss
|
-
|
-
|
-
|
-
|
-
|
(2,607
|
)
|
(2,607
|
)
|
|||||||||||||||||||
|
Balance as of December 31, 2018
|
2,028,552
|
1,985
|
17,270
|
2,340
|
800
|
(21,513
|
)
|
882
|
||||||||||||||||||||
|
Issuance of shares in rights offering, net
|
2,351,716
|
1,979
|
1,313
|
-
|
-
|
-
|
3,292
|
|||||||||||||||||||||
|
Stock-based compensation
|
-
|
-
|
-
|
-
|
141
|
-
|
141
|
|||||||||||||||||||||
|
Transaction with controlling shareholder
|
-
|
-
|
-
|
-
|
22
|
-
|
22
|
|||||||||||||||||||||
|
Comprehensive income:
|
||||||||||||||||||||||||||||
|
Foreign currency translation adjustments
|
-
|
-
|
-
|
139
|
-
|
-
|
139
|
|||||||||||||||||||||
|
Net income
|
-
|
-
|
-
|
-
|
-
|
1,793
|
1,793
|
|||||||||||||||||||||
|
Balance as of December 31, 2019
|
4,380,268
|
3,964
|
18,583
|
2,479
|
963
|
(19,720
|
)
|
6,269
|
||||||||||||||||||||
|
Issuance of shares in rights offering, net
|
1,460,089
|
1,332
|
4,263
|
5,595
|
||||||||||||||||||||||||
|
Stock-based compensation
|
121
|
121
|
||||||||||||||||||||||||||
|
Comprehensive income:
|
||||||||||||||||||||||||||||
|
Foreign currency translation adjustments
|
674
|
674
|
||||||||||||||||||||||||||
|
Net income
|
2,608
|
2,608
|
||||||||||||||||||||||||||
|
Balance as of December 31, 2020
|
5,840,357
|
5,296
|
22,846
|
3,153
|
1,084
|
(17,112
|
)
|
15,267
|
||||||||||||||||||||
|
Year ended
December 31,
|
||||||||||||
|
2020
|
2019
|
2018
|
||||||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||||||
|
Net income (loss)
|
2,608
|
1,793
|
(2,607
|
)
|
||||||||
|
Adjustments required to reconcile net income (loss) to net cash flows provided by (used in) operating activities:
|
||||||||||||
|
Depreciation
|
1,592
|
1,508
|
1,649
|
|||||||||
|
Lost (gain) on sale of property and equipment
|
(2
|
)
|
-
|
101
|
||||||||
|
Exchange rate of long term loans
|
2
|
(38
|
)
|
29
|
||||||||
|
Stock-based compensation
|
121
|
141
|
56
|
|||||||||
|
Transaction with controlling shareholder
|
-
|
22
|
49
|
|||||||||
|
Increase (decrease) in employee severance benefits, net
|
47
|
36
|
(3
|
)
|
||||||||
|
Decrease (increase) in trade receivables, net
|
(956
|
)
|
(1,277
|
)
|
790
|
|||||||
|
Increase (decrease) in operating lease right-of-use assets
|
(5,868
|
)
|
1,385
|
-
|
||||||||
|
Decrease (increase) in operating lease liabilities
|
5,942
|
(1,388
|
)
|
-
|
||||||||
|
Decrease (increase) in other receivables and prepaid expenses
|
(556
|
)
|
598
|
467
|
||||||||
|
Increase (decrease) in inventories
|
290
|
175
|
(30
|
)
|
||||||||
|
Increase (decrease) in trade payables
|
(449
|
)
|
107
|
(871
|
)
|
|||||||
|
Increase in deferred tax liabilities
|
33
|
45
|
-
|
|||||||||
|
Increase (decrease) in other liabilities and accrued expenses
|
448
|
(529
|
)
|
(443
|
)
|
|||||||
|
Net cash provided by (used in) operating activities
|
3,252
|
2,578
|
(813
|
)
|
||||||||
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
||||||||||||
|
Purchase of property and equipment
|
(1,082
|
)
|
(931
|
)
|
(619
|
)
|
||||||
|
Proceeds from disposals of property and equipment and repayment from insurance
|
(58
|
)
|
125
|
-
|
||||||||
|
Net cash used in investing activities
|
(1,140
|
)
|
(806
|
)
|
(619
|
)
|
||||||
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||||||
|
Short-term bank credit, net
|
(1,600
|
)
|
(4,181
|
)
|
986
|
|||||||
|
Repayment of short-term loan from shareholder
|
(3,661
|
)
|
561
|
1,390
|
||||||||
|
Issuance of shares in rights offering, net
|
5,594
|
3,298
|
-
|
|||||||||
|
Repayment of long-term loans
|
(183
|
)
|
(891
|
)
|
(910
|
)
|
||||||
|
Proceeds from long-term loans
|
1,141
|
558
|
378
|
|||||||||
|
Repayment of property and equipment payables
|
(477
|
)
|
(477
|
)
|
(317
|
)
|
||||||
|
Net cash provided by (used in) financing activities
|
814
|
(1,132
|
)
|
1,527
|
||||||||
|
Year ended
December 31,
|
||||||||||||
|
2020
|
2019
|
2018
|
||||||||||
|
Effect of exchange rate on cash and cash equivalents
|
181
|
(4
|
)
|
10
|
||||||||
|
Increase in cash and cash equivalents
|
3,107
|
636
|
105
|
|||||||||
|
Cash and cash equivalents at the beginning of the year
|
1,628
|
992
|
887
|
|||||||||
|
Cash and cash equivalents at end of the year
|
4,735
|
1,628
|
992
|
|||||||||
|
SUPPLEMENTAL DISCLOSURES OF CASH FLOW ACTIVITIES:
|
||||||||||||
|
Cash paid during the year for:
|
||||||||||||
|
Interest
|
163
|
232
|
212
|
|||||||||
|
Non-cash activities:
|
||||||||||||
|
Purchase of property and equipment in credit
|
666
|
350
|
118
|
|||||||||
|
Right-of-use asset recognized with corresponding lease liability
|
$
|
-
|
$
|
377
|
$
|
-
|
||||||
| NOTE 1:- |
DESCRIPTION OF BUSINESS AND GENERAL
|
|
|
a. |
General:
|
|
|
- |
Eltek Ltd. ("the Company") was established in Israel in 1970, and its ordinary shares have been publicly traded on the NASDAQ Capital Market ("NASDAQ") since 1997. Eltek Ltd. and its subsidiaries (Eltek USA Inc. and Eltek Europe
GmbH) are collectively referred to as "the Company". As of December 31, 2020, Eltek Europe GmbH is inactive.
|
|
|
- |
The Company manufactures, markets and sells custom made printed circuit boards ("PCBs"), including high density interconnect, flex-rigid and multi-layered boards. The principal markets of the Company are in Israel, Europe and North
America.
|
|
|
- |
The Company markets its product mainly to the medical technology, defense and aerospace, industrial, telecom and networking equipment, as well as to contract electronic manufacturers, among other industries.
|
|
|
- |
In June 2017, due to continued losses and the Company's limited ability to obtain additional loans from the banks at that time, the Company obtained a loan of NIS 5.0 million (approximately $ 1.4 million) from Nistec (the “First
Loan”).
In July 2017, the Company obtained a line of credit dedicated to a specific project of up to NIS 4.5 million (approximately $1.3 million) from Bank HaPoalim,
guaranteed by Nistec for a period of up to one year. In July 2018, Bank HaPoalim extended the dedicated line of credit and, in January 2019, the Company reduced the line of credit to NIS 2.25 million (approximately $ 620).
|
|
|
|
During April 2020, Bank HaPoalim approved the increase of this line of credit back to NIS 4.5 million (approximately $1.3 million) and to make this facility available to use for any purpose and not just for a specific project.
|
| NOTE 1:- |
DESCRIPTION OF BUSINESS AND GENERAL (CONT.)
|
|
|
1. |
Interest Amount:
|
|
|
a. |
A total aggregate principal loan amount of NIS 5 million (the “First Half of the Loans”) carried interest of Prime + 1%, as of September 26, 2019 and until January 7, 2020. As of January 8, 2020, and until repaid, the First Half of
the Loans shall bear the interest set forth below.
|
|
|
b. |
A total aggregate principal loan amount of NIS 5 million (the “Second Half of the Loans”) carried interest of Prime + 1.75%, as of January 1, 2019 until repaid in December 2020.
|
|
|
2. |
Payment Schedule: the interest was payable on the 10th day of each quarter, for the interest accumulated in the three (3) months prior to such payment date (except with respect to the first interest payment). The first interest
payment was payable on January 10, 2020, for 2019.
|
| NOTE 1:- |
DESCRIPTION OF BUSINESS AND GENERAL (CONT.)
|
| NOTE 1:- |
DESCRIPTION OF BUSINESS AND GENERAL (CONT.)
|
|
|
- |
The Company’s business is subject to numerous risks including, but not limited to, the impact of currency exchange rates (mainly NIS/US$), the Company's ability to implement its sales and manufacturing plans, the impact of
competition from other companies, the Company's ability to receive regulatory clearance or approval to market its products, changes in regulatory environment, domestic and global economic conditions and industry conditions, and
compliance with environmental laws and regulations. Due to these conditions and other financial and business factors, the Company's liquidity position, as well as its operating performance, was negatively affected in the past. In the
year ended December 31, 2018, the Company incurred a net loss of $2.6 million and suffered negative cash flows from its operating activities. In the year ended December 31, 2020, the Company had net income of $2.6 million as compared to
net income of $1.8 million in the year ended December 31, 2019. As of December 31, 2020, the Company's working capital amounted to $8.6 million and its accumulated deficit amounted to approximately $17.1 million. The Company's
liquidity position, as well as its operating performance, may be negatively affected by other financial and business factors, many of which are beyond its control.
|
| NOTE 1:- |
DESCRIPTION OF BUSINESS AND GENERAL (CONT.)
|
|
|
- |
An outbreak of infectious respiratory illness caused by a novel coronavirus known as COVID-19 was first detected in China in December 2019 and has now spread globally. This outbreak has resulted in travel restrictions, closed
international borders, enhanced health screenings at ports of entry and elsewhere, disruption of and delays in healthcare service preparation and delivery, prolonged quarantines, cancellations, supply chain disruptions, and lower
consumer demand, layoffs, defaults and other significant economic impacts, as well as general concern and uncertainty. The impact of this outbreak has adversely affected the economies of many nations and the entire global economy and
impacted and may impact the company in ways that cannot necessarily be foreseen.
The current severity of the pandemic and the uncertainty regarding the length of its effects could have negative consequences for the Company. During 2020, the
effects of the pandemic did not materially affected the Company’s operations, which have been deemed an “essential enterprise” by the Israeli government and the sought to operate as normal.
Some of the Company’s employees were quarantined and in some cases are working remotely, due to safety concerns. Most of the work is still preformed from the
Company's production facility. The Company’s ability to collect money, pay bills, handle customer and consumer communications, were not materially impacted. During 2020, the Company did not experience a significant change in revenues
or in the timeliness of payments of invoices and its cash position remained stable. However, during January and February 2021, the pandemic negatively impacted our operations, caused delays in supply of raw materials, created slowdown
in our production and has impacted our revenues during that period.
The Coronavirus outbreak in Israel and many other countries, could adversely affect the economies and financial markets of many countries, resulting in an
economic downturn that could affect the Company’s operating results.
The Company's management believes that its current business plans will enable the Company to continue to operate for a period of at least one year from the date
of the approval of these financial statements. In the event the Company will not be successful in generating sufficient cash from its current operations, the Company may be required to obtain additional financing from external
sources. There is no assurance that such financing will be obtained.
|
| NOTE 2:- |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
|
|
|
A. |
Basis of presentation:
|
|
|
B. |
Functional and reporting currency:
|
|
|
1. |
Assets and liabilities are translated according to the exchange rate on the consolidated balance sheet date including goodwill arising from the acquisition of the subsidiary.
|
|
|
2. |
Income and expense items are translated according to the weighted average exchange rate on a quarterly basis.
|
|
|
3. |
The resulting exchange rate differences are classified as a separate item in shareholders' equity.
|
| NOTE 2:- |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT.)
|
|
|
C. |
Exchange rates and linkage bases:
|
|
|
1. |
Balances linked to the Israeli Consumer Price Index ("CPI"), based on 2016 average prices, are recorded pursuant to contractual linkage terms of the specific assets and liabilities.
|
|
|
2. |
Details of the CPI and the representative exchange rates are as follows:
|
|
Exchange rate
|
Exchange rate
|
|||||||||||
|
Israeli CPI
|
of one US dollar
|
of one Euro
|
||||||||||
|
Points
|
NIS
|
NIS
|
||||||||||
|
December 31, 2020
|
101.1
|
3.215
|
3.944
|
|||||||||
|
December 31, 2019
|
101.8
|
3.456
|
3.878
|
|||||||||
|
December 31, 2018
|
101.2
|
3.748
|
4.292
|
|||||||||
|
%
|
||||||||||||
|
December 31, 2020
|
(0.7
|
)
|
(7.0
|
)
|
1.7
|
|||||||
|
December 31, 2019
|
0.6
|
(7.8
|
)
|
(10.0
|
)
|
|||||||
|
December 31, 2018
|
0.8
|
8.1
|
3.3
|
|||||||||
|
|
D. |
Use of estimates:
|
|
|
E. |
Cash and cash equivalents:
|
|
|
F. |
Trade accounts receivable:
|
| NOTE 2:- |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT.)
|
|
Year ended
December 31,
|
||||||||||||
|
2020
|
2019
|
2018
|
||||||||||
|
Opening balance
|
227
|
170
|
234
|
|||||||||
|
Provision for doubtful accounts
|
81
|
71
|
86
|
|||||||||
|
Customers write-offs/collection during the year
|
(111
|
)
|
(31
|
)
|
(134
|
)
|
||||||
|
Foreign currency translation adjustments
|
17
|
17
|
(16
|
)
|
||||||||
|
Closing balance
|
214
|
227
|
170
|
|||||||||
|
|
H. |
Severance pay:
|
| NOTE 2:- |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT.)
|
|
|
I. |
Property and equipment:
|
|
%
|
||
|
Machinery and equipment
|
5-33
|
|
|
Leasehold improvements
|
6-33
|
|
|
Motor vehicles
|
10-15
|
|
|
Office furniture and equipment
|
6-15
|
|
|
K. |
Income taxes:
|
| NOTE 2:- |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT.)
|
|
2020
|
2019
|
2018
|
||||
|
Dividend yield
|
0%
|
0%
|
0%
|
|||
|
Expected volatility
|
86%
|
76%
|
71%
|
|||
|
Risk-free interest
|
0.51%
|
1.47%
|
2.89%
|
|||
|
Contractual term
|
10 years
|
10 years
|
10 years
|
|||
|
Forfeiture rate
|
0%
|
0%
|
0%
|
| NOTE 2:- |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT.)
|
| NOTE 2:- |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT.)
|
|
|
N. |
Earnings per ordinary share:
|
|
|
O. |
Concentration of credit risk:
|
|
|
P. |
Research and development costs:
|
|
|
Q. |
Commitments and contingencies:
|
| NOTE 2:- |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT.)
|
|
|
R. |
Fair value measurements:
|
|
|
Level 1
|
- | Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. |
|
|
Level 2
|
- | Significant other observable inputs based on market data obtained from sources independent of the reporting entity. |
|
|
Level 3
|
- | Unobservable inputs which are supported by little or no market activity. |
|
|
S. |
Comprehensive income (loss):
|
|
Year ended December 31,
|
||||||||||||
|
2020
|
2019
|
2018
|
||||||||||
|
Foreign currency translation adjustments
|
674
|
139
|
(75
|
)
|
||||||||
|
Total accumulated other comprehensive income (loss)
|
674
|
139
|
(75
|
)
|
||||||||
| NOTE 2:- |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT.)
|
|
|
T. |
Leases:
|
|
|
U. |
Impact of recently issued and adopted accounting standards:
In June 2016, the FASB issued ASU 2016-13, "Financial Instruments – Credit Losses (Topic 326)". ASU 2016-13 requires that financial assets
measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis. The measurement of expected credit losses is
based upon historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. ASU 2016-13 will become effective for annual and interim periods beginning after
December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The standard did not have an
effect on the Company's consolidated financial statements.
|
| NOTE 2:- |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT.)
|
|
|
V. |
New accounting pronouncements not yet effective:
In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU
2019-12”), which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to
improve consistent application. This standard will be effective for the Company beginning January 1, 2021 and must be applied on a modified retrospective basis. This standard will not have a material impact on the Company's
financial statements and disclosures.
|
|
|
W. |
Reclassifications:
|
| NOTE 3:- |
CASH AND CASH EQUIVALENTS
|
|
December 31,
|
||||||||
|
2020
|
2019
|
|||||||
|
Denominated in U.S. dollars
|
3,920
|
1,034
|
||||||
|
Denominated in NIS
|
166
|
129
|
||||||
|
Denominated in Euro
|
649
|
465
|
||||||
|
4,735
|
1,628
|
|||||||
| NOTE 4:- |
INVENTORIES
|
|
December 31,
|
||||||||
|
2020
|
2019
|
|||||||
|
Raw materials
|
1,821
|
1,860
|
||||||
|
Work-in-progress
|
1,348
|
1,607
|
||||||
|
Finished goods
|
535
|
268
|
||||||
|
3,704
|
3,735
|
|||||||
| NOTE 5:- |
OTHER ACCOUNTS RECEIVABLE AND PREPAID EXPENSES
|
|
December 31,
|
||||||||
|
2020
|
2019
|
|||||||
|
Prepaid expenses
|
619
|
530
|
||||||
|
Receivables from government authorities
|
568
|
2
|
||||||
|
Receivables from employees
|
6
|
8
|
||||||
|
Others
|
126
|
135
|
||||||
|
1,319
|
675
|
|||||||
| NOTE 6:- |
PROPERTY AND EQUIPMENT, NET
|
|
December 31,
|
||||||||
|
2020
|
2019
|
|||||||
|
Cost:
|
||||||||
|
Machinery and equipment
|
40,268
|
35,999
|
||||||
|
Leasehold improvements
|
9,656
|
8,917
|
||||||
|
Motor vehicles
|
81
|
77
|
||||||
|
Office furniture and equipment
|
869
|
799
|
||||||
|
50,874
|
45,792
|
|||||||
|
Accumulated depreciation:
|
||||||||
|
Machinery and equipment
|
(33,892
|
)
|
(30,349
|
)
|
||||
|
Leasehold improvements
|
(8,991
|
)
|
(8,019
|
)
|
||||
|
Motor vehicles
|
(56
|
)
|
(59
|
)
|
||||
|
Office furniture and equipment
|
(672
|
)
|
(604
|
)
|
||||
|
(43,611
|
)
|
(39,031
|
)
|
|||||
|
Depreciated cost
|
7,263
|
6,761
|
||||||
| NOTE 7:- |
SHORT-TERM CREDIT AND CURRENT MATURITIES OF LONG-TERM DEBT
|
|
Annual interest rate at
|
||||||||||||
|
December 31,
|
December 31,
|
|||||||||||
|
2020
|
2020
|
2019
|
||||||||||
|
In NIS bears interest rate of Prime+0.85%
|
2.45
|
%
|
373
|
1,326
|
||||||||
|
Short term credit from others
|
4.15
|
%
|
-
|
612
|
||||||||
|
Long-term debt from banks in NIS bears interest of Prime+1.5% to Prime+1.75%
|
3.1% - 3.35
|
%
|
303
|
182
|
||||||||
|
676
|
2,120
|
|||||||||||
| NOTE 8:- |
OTHER PAYABLE AND ACCRUED EXPENSES
|
|
December 31,
|
||||||||
|
2020
|
2019
|
|||||||
|
Accrued payroll including amounts due to government authorities
|
994
|
968
|
||||||
|
Provision for vacation and other employee benefits
|
1,872
|
1,524
|
||||||
|
Accrued expenses
|
441
|
378
|
||||||
|
Provision for contingent liabilities (Note 12c)
|
117
|
42
|
||||||
|
Other liabilities
|
407
|
206
|
||||||
|
3,831
|
3,118
|
|||||||
| NOTE 9:- |
LONG-TERM DEBT, EXCLUDING CURRENT MATURITIES
|
|
|
Annual interest
|
|||||||||||
|
rate at
|
||||||||||||
|
December 31
|
December 31,
|
|||||||||||
|
2020
|
2020
|
2019
|
||||||||||
|
Linkage terms:
|
||||||||||||
|
U.S. dollar
|
3.5% - 5%
|
|
-
|
381
|
||||||||
|
NIS
|
3.1% - 3.35%
|
|
1,659
|
664
|
||||||||
|
Euro
|
206
|
-
|
||||||||||
|
1,865
|
1,045
|
|||||||||||
|
Less - current maturities
|
(370
|
)
|
(658
|
)
|
||||||||
|
1,495
|
387
|
|||||||||||
|
Long-term loan
|
||||
|
2021
|
369
|
|||
|
2022
|
526
|
|||
|
2023
|
485
|
|||
|
2024
|
321
|
|||
|
2025
|
164
|
|||
|
1,865
|
||||
| NOTE 10:- |
EMPLOYEE SEVERANCE BENEFITS
|
|
|
a. |
The Company has an approval from the Israeli Ministry of Labor and Social Welfare, pursuant to the terms of Section 14 of the Israeli Severance Pay Law, 1963, according to which the Company's current deposits in the pension fund
and/or with the insurance company exempt it from any additional severance obligations to the employees for whom such depository payments were made.
|
|
|
b. |
The Company's employees participate in a pension plan or individual insurance policies that are purchased by them. The Company's liability for severance obligations for the employees employed for one year or more is discharged by
making regular deposits with a pension fund or the insurance policies. Under Israeli law, there is no liability for severance pay in respect of employees who have not completed one year of employment. The amount deposited with the
pension fund or the insurance policies is based on salary components as prescribed in the employment agreement. The custody and management of the amounts so deposited are independent of the Company and accordingly, such amounts funded
and related liabilities are not reflected in the balance sheet.
|
|
|
c. |
Expenses (income) recorded in respect of the unfunded liability for employee severance payments for the years ended December 31, 2020, 2019, and 2018 were $57, $(20) and $87, respectively.
|
| NOTE 11:- |
LEASES
|
|
|
a. |
The components of operating lease costs were as follows:
|
|
Year ended December 31, 2020
|
||||
|
Operating lease cost
|
$
|
1,260
|
||
|
Sublease income
|
(-
|
)
|
||
|
Total net lease costs
|
$
|
1,260
|
||
|
|
b. |
Supplemental balance sheet information related to operating leases is as follows:
|
|
As of December 31, 2020
|
||||
|
Operating lease ROU assets
|
$
|
8,948
|
||
|
Operating lease liabilities, current
|
$
|
742
|
||
|
Operating lease liabilities, long-term
|
$
|
8,272
|
||
|
Weighted average remaining lease term (in years)
|
3.99
|
|||
|
Weighted average discount rate
|
5.30
|
%
|
||
|
|
c. |
Future lease payments under operating leases as of December 31, 2020, are as follows:
|
|
As of December 31, 2020
|
||||
|
|
||||
|
2021
|
$
|
1,211
|
||
|
2022
|
1,187
|
|||
|
2023
|
1,080
|
|||
|
2024
|
1,049
|
|||
|
2032- 2025
|
7,647
|
|||
|
|
||||
|
Total undiscounted lease payments
|
$
|
12,174
|
||
|
Less: imputed interest
|
(3,160
|
)
|
||
|
|
||||
|
Present value of lease liabilities
|
$
|
9,014
|
||
| NOTE 12:- |
COMMITMENTS AND CONTINGENT LIABILITIES
|
|
|
a. |
Pledges:
|
|
|
1. |
The Company has pledged certain items of its equipment and the rights to any insurance claims on such items to secure its debts to banks, as well as placed floating liens on all of its remaining assets in favor of the banks.
|
|
|
2. |
The Company has also pledged machines to secure its indebtedness to certain suppliers that provided financing for such equipment.
|
|
|
b. |
Indemnification agreement:
|
|
|
c. |
Contingent Liabilities:
|
| NOTE 13:- |
SHAREHOLDERS' EQUITY
|
|
Number of options
|
Weighted-average exercise
price
|
Weighted- average remaining contractual life
(in months)
|
Aggregate intrinsic
value
(in thousands)
|
|||||||||||||
|
Outstanding at January 1, 2020
|
123,519
|
4.65
|
95
|
12
|
||||||||||||
|
Granted
|
16,014
|
4.35
|
106
|
-
|
||||||||||||
|
Exercised
|
-
|
-
|
-
|
-
|
||||||||||||
|
Forfeited
|
(5,000
|
)
|
6.38
|
107
|
-
|
|||||||||||
|
Outstanding at December 31, 2020
|
134,533
|
4.55
|
96
|
108
|
||||||||||||
|
Exercisable at December 31, 2020
|
65,021
|
4.37
|
93
|
56
|
||||||||||||
| NOTE 13:- |
SHAREHOLDERS' EQUITY (CONT.)
|
| NOTE 14:- |
BASIC AND DILUTED NET EARNINGS PER SHARE
|
|
Year ended
December 31,
|
||||||||||||
|
2020
|
2019
|
2018
|
||||||||||
|
Numerator:
|
||||||||||||
|
Profit (loss) attributable to Eltek Ltd shareholders'
|
2,608
|
1,793
|
(2,607
|
)
|
||||||||
|
Denominator:
|
||||||||||||
|
Denominator for basic profit (loss) per share weighted-average number of shares outstanding
|
4,495,329
|
3,734,189
|
2,028,552
|
|||||||||
|
Effect of diluting securities:
|
||||||||||||
|
Employee stock options
|
5,815
|
128
|
-
|
|||||||||
|
Denominator for diluted profit (loss) per share - adjusted weighted average shares and assumed exercises
|
4,501,144
|
3,734,317
|
2,028,552
|
|||||||||
|
|
a. |
Customers who accounted for over 10% of the total consolidated revenues:
|
|
Year ended
December 31,
|
||||||||||||
|
2020
|
2019
|
2018
|
||||||||||
|
Customer A - Sales of manufactured products
|
18.9
|
%
|
19.5
|
%
|
12.0
|
%
|
||||||
|
Customer B - Sales of manufactured products
|
11.6
|
%
|
11.5
|
%
|
9.3
|
%
|
||||||
|
|
b. |
Revenues by geographic areas:
|
|
Israel
|
20,792
|
19,659
|
18,940
|
|||||||||
|
North America
|
6,009
|
6,434
|
6,973
|
|||||||||
|
Netherlands
|
3,808
|
2,898
|
3,302
|
|||||||||
|
India
|
3,292
|
3,809
|
2,239
|
|||||||||
|
Others
|
2,806
|
1,994
|
488
|
|||||||||
|
36,707
|
34,794
|
33,939
|
| NOTE 16:- |
FINANCIAL EXPENSES, NET
|
|
Year ended
December 31,
|
||||||||||||
|
2020
|
2019
|
2018
|
||||||||||
|
Interest on long-term banks
|
16
|
19
|
152
|
|||||||||
|
Bank charges and short-term credit
|
178
|
287
|
232
|
|||||||||
|
Foreign exchange loss, net
|
127
|
105
|
24
|
|||||||||
|
Other financing expenses, net
|
16
|
29
|
67
|
|||||||||
|
337
|
440
|
475
|
||||||||||
| NOTE 17:- |
OTHER INCOME (LOSS), NET
|
| NOTE 18:- |
TAXES ON INCOME
|
|
|
a. |
Tax laws applicable to the Company:
|
| NOTE 18:- |
TAXES ON INCOME (CONT.)
|
| NOTE 18:- |
TAXES ON INCOME (CONT.)
|
|
|
b. |
Tax rates applicable to the Group:
|
|
|
1. |
In December 2016, the Israeli Parliament approved the Economic Efficiency Law (Legislative Amendments for Applying the Economic Policy for the 2017 and 2018 Budget Years), 2016 which reduces the corporate income tax rate to 24%
(instead of 25%) effective from January 1, 2017 and to 23% effective from January 1, 2018.
|
|
|
2. |
The tax rates of the Company's non-Israeli subsidiaries range between 28% - 30%.
|
|
|
3. |
On December 22, 2017, the U.S. enacted the Tax Cuts and Jobs Act (the "Act"), which among other provisions, reduced the U.S. corporate tax rate from 35% to 21%, effective January 1, 2018.
|
|
|
c. |
Carryforward losses for tax purposes and tax credits carryforwards:
|
|
|
d. |
Income tax assessments:
|
|
|
e. |
Profit before tax and taxes on income included in the consolidated statements of comprehensive income:
|
|
Year ended December 31,
|
||||||||||||
|
2020
|
2019
|
2018
|
||||||||||
|
Income (loss) before income tax expense:
|
||||||||||||
|
Israel
|
2,504
|
1,741
|
(2,663
|
)
|
||||||||
|
Foreign jurisdictions
|
175
|
129
|
119
|
|||||||||
|
2,679
|
1,870
|
(2,544
|
)
|
|||||||||
|
Current tax expense:
|
||||||||||||
|
Israel
|
-
|
-
|
14
|
|||||||||
|
Foreign jurisdictions
|
38
|
32
|
49
|
|||||||||
|
38
|
32
|
63
|
||||||||||
|
Deferred taxes:
|
||||||||||||
|
Israel
|
33
|
45
|
-
|
|||||||||
|
33
|
45
|
-
|
||||||||||
|
Income tax expense
|
71
|
77
|
63
|
|||||||||
| NOTE 18:- |
TAXES ON INCOME (CONT.)
|
|
|
f. |
Reconciliation of the theoretical income tax benefit to the actual income tax expense:
|
|
Year ended
December 31,
|
||||||||||||
|
2020
|
2019
|
2018
|
||||||||||
|
Income (loss) before income tax expense as reported in the consolidated statements of comprehensive income
|
2,679
|
1,870
|
(2,544
|
)
|
||||||||
|
Statutory tax rates
|
23
|
%
|
23
|
%
|
23
|
%
|
||||||
|
Theoretical tax expense (benefit) calculated
|
616
|
430
|
(585
|
)
|
||||||||
|
Losses and other items for which a valuation allowance was provided
|
419
|
(38
|
)
|
271
|
||||||||
|
Change in effective on corporate tax rate
|
-
|
-
|
||||||||||
|
Realization of carryforward tax losses for which valuation allowance was provided
|
(692
|
)
|
(250
|
)
|
-
|
|||||||
|
Tax benefit arising from "Preferred enterprises"
|
(303
|
)
|
(109
|
)
|
189
|
|||||||
|
Foreign tax rate differential in subsidiaries
|
(3
|
)
|
22
|
22
|
||||||||
|
Non-deductible items and others
|
34
|
22
|
166
|
|||||||||
|
Total
|
(545
|
)
|
(353
|
)
|
648
|
|||||||
|
Income tax expense
|
71
|
77
|
63
|
|||||||||
| NOTE 18:- |
TAXES ON INCOME (CONT.)
|
|
|
g. |
Deferred tax assets and liabilities:
|
|
December 31,
|
||||||||
|
2020
|
2019
|
|||||||
|
Deferred tax assets:
|
||||||||
|
Net operating loss carryforwards (in Israel)
|
3,284
|
3,851
|
||||||
|
Capital loss carryforwards (in Israel)
|
2,485
|
2,073
|
||||||
|
Operating lease
|
1,442
|
396
|
||||||
|
Tax credit carryforward
|
1,171
|
1,085
|
||||||
|
Reserves and other
|
241
|
241
|
||||||
|
Total gross deferred taxes
|
8,623
|
7,646
|
||||||
|
Less valuation allowance
|
(6,195
|
)
|
(6,298
|
)
|
||||
|
Deferred tax assets, net
|
2,428
|
1,348
|
||||||
|
Deferred tax liabilities:
|
||||||||
|
Undistributed income of subsidiaries
|
(263
|
)
|
(232
|
)
|
||||
|
Operating lease
|
(1,432
|
)
|
(398
|
)
|
||||
|
Property and equipment
|
(817
|
)
|
(763
|
)
|
||||
|
Total deferred tax liabilities
|
(2,512
|
)
|
(1,393
|
)
|
||||
|
Net deferred tax liabilities
|
(84
|
)
|
(45
|
)
|
| NOTE 18:- |
TAXES ON INCOME (CONT.)
|
|
|
h. |
Accounting for uncertainty in income taxes:
|
| NOTE 19:- |
FINANCIAL INSTRUMENTS AND RISK MANAGEMENT
|
| NOTE 20:- |
RELATED PARTY BALANCES AND TRANSACTIONS
|
|
|
a. |
Balances with related parties:
|
|
December 31,
|
||||||||
|
2020
|
2019
|
|||||||
|
Trade accounts receivable
|
92
|
47
|
||||||
|
Trade accounts payable
|
61
|
115
|
||||||
|
Controlling shareholder loans
|
-
|
3,472
|
||||||
|
|
b. |
Transactions with related parties:
|
|
Year ended
December 31,
|
||||||||||||
|
2020
|
2019
|
2018
|
||||||||||
|
Revenues
|
514
|
226
|
821
|
|||||||||
|
Purchases, general and administrative expenses
|
314
|
323
|
313
|
|||||||||
|
Interest on loans from controlling shareholder
|
102
|
121
|
113
|
|||||||||
| NOTE 20:- |
RELATED PARTY BALANCES AND TRANSACTIONS (CONT.)
|
| NOTE 20:- |
RELATED PARTY BALANCES AND TRANSACTIONS (CONT.)
|
|
|
a. |
Eltek pays Nistec monthly managements fees of NIS 90 ($28).
|
|
|
b. |
Subject to Company’s reimbursement policy approved by the Audit Committee on May 15, 2016, Mr. Nissan shall receive reimbursement of travel expenses (other than food and beverage expenses) while traveling internationally on behalf of
the Company, provided that such reimbursement shall not exceed an aggregate amount of NIS 10 per calendar quarter.
|
|
|
c. |
Mr. Nissan shall receive reimbursement of food and beverage expenses while traveling internationally on behalf of the Company, against receipts, in accordance with the Israeli Income Tax Regulations (Deduction of Certain Expenses)
1972.
|
|
|
a. |
The extension of the Directors and Officers Indemnity Agreement with Mr. Yitzhak Nissan.
|
|
|
b. |
The extension of the Exculpation Letter for an additional three (3) year period
|
|
|
c. |
The application of the Company’s directors and officers liability insurance policy with respect to Mr. Yitzhak Nissan
|
|
|
d. |
The revised terms of employment of Yitzhak Nissan's daughter who is employed by the Company as special project manager.
|
|
|
ELTEK LTD.
By:
/s/ Eli Yaffe
Name: Eli Yaffe
Title: Chief Executive Officer
By:
/s/ Alon Mualem
Name: Alon Mualem
Title: Chief Financial Officer
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|